Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

76.17

+0.67 (0.89%)

Aug 12, 2026, 11:04 AM EDT - Market open

Nektar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,573	862	173	108	426	2,506
Market Cap Growth	486.75%	398.70%	59.68%	-74.61%	-82.99%	-18.16%
Enterprise Value	1,985	701.62	20.11	-77.64	52.66	1,915
Last Close Price	76.17	42.28	13.95	8.48	33.90	202.65

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	15.88	15.88	15.88	15.88	15.88
PS Ratio	45.85	15.60	1.76	1.20	4.63	24.59
PB Ratio	3.86	9.59	2.84	0.83	1.16	3.69
P/TBV Ratio	2.58	7.94	3.15	0.82	1.46	4.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	35.28	12.70	0.20	-0.86	0.57	18.79
EV/EBITDA Ratio	-	-	-	0.30	-	-
EV/EBIT Ratio	-	-	-	0.29	-	-
EV/FCF Ratio	-	-	-	0.40	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.11	0.73	1.36	0.75	0.31	0.19
Net Debt / Equity Ratio	-0.84	-1.78	-2.51	-1.42	-1.02	-0.87
Net Debt / EBITDA Ratio	3.63	1.15	1.51	0.73	1.03	1.37
Net Debt / FCF Ratio	2.38	0.77	0.86	0.96	1.21	1.38
Asset Turnover	0.11	0.19	0.28	0.16	0.10	0.08
Inventory Turnover	-	-	3.81	1.91	1.24	1.60
Quick Ratio	9.85	4.59	4.16	5.95	7.49	8.88
Current Ratio	10.21	4.97	4.26	6.45	8.00	9.34
Return on Equity (ROE)	-45.67%	-206.35%	-124.10%	-110.95%	-70.39%	-59.64%
Return on Assets (ROA)	-25.78%	-47.92%	-29.92%	-47.53%	-41.52%	-33.63%
Return on Invested Capital (ROIC)	-1305.60%	-	-	-	-926.84%	-351.06%
Return on Capital Employed (ROCE)	-28.88%	-59.70%	-35.71%	-53.31%	-44.93%	-36.34%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-39.76%	-23.05%	-8.24%	-1.53%	-2.09%	-2.64%
Total Shareholder Return	-39.76%	-23.05%	-8.24%	-1.53%	-2.09%	-2.64%

SEC Filings: 10-K · 10-Q